Kapil Khambholja

Kapil Khambholja serves as the Executive Director and Global Head of MW, RWE & HEOR at Catalyst Clinical Research since January 2024, focusing on oncology and multi-therapeutic services. Prior to this, Kapil was the Head of Product Strategy and Co-founder & Chief Scientific Officer at Genpro Research, leading product strategy and automation until a merger with Catalyst Clinical Research in July 2023. Kapil's previous experience includes roles at SIRO Clinpharm Pvt. Ltd. and Novartis, where responsibilities spanned project management and medical writing. In academia, Kapil held a position as Assistant Professor at Ganpat University and was a Senior Research Fellow at the Institute of Chemical Technology. Educational qualifications include a Ph.D. in Pharmacy from Ganpat University, a Master of Pharmacy from the University of Mumbai, and a Bachelor of Pharmacy from S K Patel College of Pharmaceutical Edu & Res.